184 related articles for article (PubMed ID: 30606672)
1. Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.
Wang X; Bai E; Zhou H; Sha S; Miao H; Qin Y; Liu Z; Wang J; Zhang H; Lei M; Liu J; Hai O; Zhu Y
Bioorg Med Chem; 2019 Feb; 27(3):533-544. PubMed ID: 30606672
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.
Zhang Y; Xie X; Wang X; Wen T; Zhao C; Liu H; Zhao B; Zhu Y
Bioorg Med Chem; 2021 May; 38():116114. PubMed ID: 33831696
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer.
Wang X; Wen T; Miao H; Hu W; Lei M; Zhu Y
Bioorg Med Chem; 2022 Nov; 74():117050. PubMed ID: 36228523
[TBL] [Abstract][Full Text] [Related]
4. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
5. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.
Cervi G; Magnaghi P; Asa D; Avanzi N; Badari A; Borghi D; Caruso M; Cirla A; Cozzi L; Felder E; Galvani A; Gasparri F; Lomolino A; Magnuson S; Malgesini B; Motto I; Pasi M; Rizzi S; Salom B; Sorrentino G; Troiani S; Valsasina B; O'Brien T; Isacchi A; Donati D; D'Alessio R
J Med Chem; 2014 Dec; 57(24):10443-54. PubMed ID: 25474526
[TBL] [Abstract][Full Text] [Related]
7. Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer.
Du Q; Feng X; Wang Y; Xu X; Zhang Y; Qu X; Li Z; Bian J
Eur J Med Chem; 2019 Nov; 182():111629. PubMed ID: 31445231
[TBL] [Abstract][Full Text] [Related]
8. A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
Segura-Cabrera A; Tripathi R; Zhang X; Gui L; Chou TF; Komurov K
Sci Rep; 2017 Mar; 7():44912. PubMed ID: 28322292
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions.
Zhang Y; Meng X; Tang H; Cheng M; Yang F; Xu W
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):344-353. PubMed ID: 31851852
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolo[2,3-b]pyridine-3-one derivatives as novel fibroblast growth factor receptor 4 inhibitors for the treatment of hepatocellular carcinoma.
Jin Q; Zhang D; Gao M; Jiang C; Zhang J
Bioorg Med Chem; 2021 Jan; 29():115862. PubMed ID: 33218898
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and pharmacological evaluation of N4,N6-disubstituted pyrimidine-4,6-diamine derivatives as potent EGFR inhibitors in non-small cell lung cancer.
Zhang Y; Lv H; Luo L; Xu Y; Pan Y; Wang Y; Lin H; Xiong J; Guo P; Zhang J; Li X; Ye F
Eur J Med Chem; 2018 Sep; 157():1300-1325. PubMed ID: 30195240
[TBL] [Abstract][Full Text] [Related]
13. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of N-hydroxypropenamides based on adamantane to overcome resistance in NSCLC.
Bao X; Sun Y; Bao C; Zhang J; Zou S; Yang J; Wu C; Wang L; Chen G
Bioorg Chem; 2019 May; 86():696-704. PubMed ID: 30831531
[TBL] [Abstract][Full Text] [Related]
15. A Non-Competitive Inhibitor of VCP/p97 and VPS4 Reveals Conserved Allosteric Circuits in Type I and II AAA ATPases.
Pöhler R; Krahn JH; van den Boom J; Dobrynin G; Kaschani F; Eggenweiler HM; Zenke FT; Kaiser M; Meyer H
Angew Chem Int Ed Engl; 2018 Feb; 57(6):1576-1580. PubMed ID: 29271116
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
[TBL] [Abstract][Full Text] [Related]
17. Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive p97 Inhibitors for Potential Anticancer Therapy.
Wang F; Li S; Gan T; Stott GM; Flint A; Chou TF
ChemMedChem; 2020 Apr; 15(8):685-694. PubMed ID: 32162487
[TBL] [Abstract][Full Text] [Related]
18. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
Martínez-García D; Pérez-Hernández M; Korrodi-Gregório L; Quesada R; Ramos R; Baixeras N; Pérez-Tomás R; Soto-Cerrato V
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412593
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma.
Zhang W; Wang X; Zhang H; Wen T; Yang L; Miao H; Wang J; Liu H; Yang X; Lei M; Zhu Y
Bioorg Med Chem; 2021 Jun; 40():116182. PubMed ID: 33971487
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
